Tela Bio Inc. (TELA)
NASDAQ (NMS) NASDAQ (NMS) Primary 
TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates
TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.25 per share a year ago.
TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript
TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates
TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.23 per share a year ago.
TELA Bio, Inc. (TELA) Q3 2025 Earnings Call Transcript
TELA Bio, Inc. ( TELA ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Antony Koblish - Co-founder, CEO & Director Jeffrey Blizard - President of TELA Bio & Director Roberto Cuca - CFO & COO Jim Hagen Conference Call Participants Louisa Smith - Gilmartin Group LLC Caitlin Cronin - Canaccord Genuity Corp., Research Division Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Samantha Munoz Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates
TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.42 per share a year ago.
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.51 per share a year ago.
TELA Bio, Inc. (TELA) Q2 2025 Earnings Call Transcript
TELA Bio, Inc. (NASDAQ:TELA ) Q2 2025 Earnings Conference Call August 11, 2025 4:30 PM ET Company Participants Antony Koblish - Co-founder, CEO & Director Jeffrey Blizard - President of TELA Bio & Director Roberto E. Cuca - CFO & COO Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Frank James Takkinen - Lake Street Capital Markets, LLC, Research Division Michael Anthony Sarcone - Jefferies LLC, Research Division Louisa Smith - Gilmartin Group LLC Operator Thank you for standing by, and welcome to TELA Bio's Second Quarter 2025 Earnings Conference Call.
TELA Bio, Inc. (TELA) Q1 2025 Earnings Call Transcript
TELA Bio, Inc. (NASDAQ:TELA ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Louisa Smith - The Gilmartin Group Antony Koblish - Co-founder, President & Chief Executive Office Roberto Cuca - Chief Operating Officer & Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Michael Sarcone - Jefferies David Turkaly - Citizens JMP Operator Good afternoon ladies and gentlemen and welcome to the TELA Bio First Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode.
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.23 per share a year ago.
TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript
TELA Bio, Inc. (NASDAQ:TELA ) Q4 2024 Earnings Conference Call March 20, 2025 4:30 PM ET Company Participants Greg Chodaczek - The Gilmartin Group Antony Koblish - Co-founder, President and Chief Executive Office Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Caitlin Cronin - Canaccord Genuity David Turkaly - Citizens Matt O'Brien - Piper Sandler Michael Sarcone - Jefferies Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates
TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.23 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.53 per share a year ago.
TELA Bio, Inc. (TELA) Q3 2024 Earnings Call Transcript
TELA Bio, Inc. (NASDAQ:TELA ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Louisa Smith - Vice President, Gilmartin Group Tony Koblish - President & Chief Executive Officer Roberto Cuca - Chief Operating Officer & Chief Financial Officer Conference Call Participants Caitlin Cronin - Canaccord Genuity Frank Takkinen - Lake Street Capital Markets Michael Sarcone - Jefferies Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
